Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice

Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice

Obeticholic acid (OCA) has been examined to treat non-alcoholic steatohepatitis (NASH), but has unsatisfactory antifibrotic effect and deficient responsive rate in recent phase III clinical trial. Using a prolonged western diet-feeding murine NASH model, we show that OCA-shaped gut microbiota induce...

Full description

Bibliographic Details
Main Authors:	Aoxiang Zhuge, Shengjie Li, Yin Yuan, Shengyi Han, Jiafeng Xia, Qiangqiang Wang, Shuting Wang, Pengcheng Lou, Bo Li, Lanjuan Li
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Series:	Redox Biology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213231722003548

Similar Items

Obeticholic acid and ferrostatin-1 differentially ameliorate non-alcoholic steatohepatitis in AMLN diet-fed ob/ob mice
by: Shengjie Li, et al.
Published: (2022-12-01)

Resynchronized rhythmic oscillations of gut microbiota drive time-restricted feeding induced nonalcoholic steatohepatitis alleviation
by: Jiafeng Xia, et al.
Published: (2023-12-01)

Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice
by: Aoxiang Zhuge, et al.
Published: (2022-06-01)

Triglyceride peroxidation progression in lipid droplets of hepatocytes in nonalcoholic steatohepatitis
by: Kota Saito, et al.
Published: (2024-02-01)

The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
by: Hui Xiang, et al.
Published: (2022-02-01)

Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis.
by: Luciano Adorini, et al.
Published: (2024-01-01)

Multi-Omics Analysis Reveals the Protection of Gasdermin D in Concanavalin A-Induced Autoimmune Hepatitis
by: Kaicen Wang, et al.
Published: (2022-10-01)

Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
by: Sebastião M.B. Duarte, et al.
Published: (2019-05-01)

Akkermansia muciniphila-derived acetate activates the hepatic AMPK/SIRT1/PGC-1α axis to alleviate ferroptosis in metabolic-associated fatty liver disease
by: Aoxiang Zhuge, et al.
Published: (2025-01-01)

Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
by: Ludovico Abenavoli, et al.
Published: (2018-10-01)

Oligonucleotide therapies for nonalcoholic steatohepatitis
by: Sixu Li, et al.
Published: (2024-06-01)

Challenges and opportunities in nonalcoholic steatohepatitis
by: Wang Xiaobo
Published: (2022-08-01)

Effects of apical sodium-bile acid transporter inhibitor and obeticholic acid co-treatment in experimental non-alcoholic steatohepatitis
by: David J. Matye, et al.
Published: (2022-12-01)

Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism
by: Yuanyuan Lei, et al.
Published: (2022-11-01)

Necroptosis in Nonalcoholic Steatohepatitis
by: Jérémie Gautheron, PhD, et al.
Published: (2015-05-01)

Uncovered issues in the overview of nonalcoholic steatohepatitis
by: Chia-Chi Wang
Published: (2011-12-01)

Akkermansia muciniphila alleviates high‐fat‐diet‐related metabolic‐associated fatty liver disease by modulating gut microbiota and bile acids
by: Wenrui Wu, et al.
Published: (2023-10-01)

Nonalcoholic Steatohepatitis: An Evolving Diagnosis
by: Brent A Neuschwander-Tetri
Published: (2000-01-01)

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
by: Anca Smaranda Farmazon, et al.
Published: (2018-09-01)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
by: Gopanandan Parthasarathy, et al.
Published: (2020-04-01)

The metabolic basis of nonalcoholic steatohepatitis
by: Manu V. Chakravarthy, et al.
Published: (2020-10-01)

Identification of pyroptosis-related gene signature in nonalcoholic steatohepatitis
by: Fei Mao, et al.
Published: (2024-02-01)

Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study.
by: Vincent Wai-Sun Wong, et al.
Published: (2013-01-01)

Regulation of lipid metabolism by obeticholic acid in hyperlipidemic hamsters
by: Bin Dong, et al.
Published: (2017-02-01)

Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated γδT17 cell and macrophage polarization
by: Yuqiu Han, et al.
Published: (2023-12-01)

Dendrobium officinale alleviates high-fat diet-induced nonalcoholic steatohepatitis by modulating gut microbiota
by: Gege Tian, et al.
Published: (2023-02-01)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023-02-01)

The polarizable and reprogrammable identity of Kupffer cells in Nonalcoholic Steatohepatitis
by: Zahr Tarik, et al.
Published: (2022-08-01)

Orlistat for overweight subjects with nonalcoholic steatohepatitis.
by: Dowman, J, et al.
Published: (2009)

Nonalcoholic Steatohepatitis in Nondiabetic Obese Patients
by: Idilio Zamin, et al.
Published: (2002-01-01)

Human Nonalcoholic Steatohepatitis on a Chip
by: May S. Freag, et al.
Published: (2021-02-01)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
by: Mindy C.W. Lam, et al.
Published: (2012-07-01)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
by: Seonghwan Hwang, et al.
Published: (2021-10-01)

The regulatory state of nonalcoholic steatohepatitis and metabolism
by: Stephanie O. Omokaro, et al.
Published: (2020-10-01)

Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis
by: S.M. Touhidul Islam, et al.
Published: (2020-09-01)

Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
by: Haiou Li, et al.
Published: (2020-06-01)

Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01)

Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[S]
by: Ariel E. Feldstein, et al.
Published: (2010-10-01)

Obeticholic Acid for Primary Biliary Cholangitis
by: Annarosa Floreani, et al.
Published: (2022-10-01)

Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice
by: Panshuang Qiao, et al.
Published: (2022-08-01)